Session Information
ASRM 65th Annual Meeting
Click here to go to the previous page
Male Reproduction in 2009: New Clinical and Scientific Paradigms
Track
:
PG Track Four
Program Code:
PG12
Date:
Sunday, October 18, 2009
Time:
8:15 AM to 5:00 PM
EST
Location:
C204
CHAIR
(S):
Nancy L. Brackett, Ph.D., H.C.L.D.
Dana A. Ohl, M.D., University of Michigan
SPEAKER
(S):
Trevor G. Cooper, Ph.D.
Dolores J. Lamb, Ph.D.,
Description
Male factors are often the cause of a couple’s failure to conceive. Discussion and evidence of this quickly expanding field can be found not only in the scientific literature, but in the popular press and on the Internet as well. New technologies with implications for the treatment of male infertility are being developed and advancing rapidly. It is important, therefore, that practitioners are aware of progress in technology that may have an impact on treatments for male infertility now or in the future. The role of reproductive medicine professionals is vital in educating not only patients dealing with male infertility, but clinicians in other specialties who also may treat these patients.
This course is designed for physicians and laboratory professionals in the fields of reproductive medicine, urology, male infertility, andrology, and sexual medicine and will focus on optimizing outcomes for patients with male infertility.
Concentration will be on best physician practice in several key areas in the treatment of patients with male infertility, including pharmacologic management of erectile and ejaculatory dysfunction, investigation of erectile dysfunction as an indicator of metabolic syndrome, treatment of infertility in men with spinal cord injury, and the application of the newest laboratory findings to the treatment of male infertility.
LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:
1. Explain the basis for current recommendations regarding the pharmacologic management of erectile dysfunction and
ejaculatory dysfunction.
2. Describe the physiologic basis for erectile dysfunction as an indicator of metabolic syndrome.
3. Implement current recommendations for the treatment of infertility in men with spinal cord injury based on current
recommendations.
4. Summarize the recent revisions of the World Health Organization Semen Manual.
5. Apply the newest findings in epigenetics and advanced technologies to the treatment of male infertility.
To purchase a downloadable PDF of the PG course syllabus or syllabi, click here.
This course is designed for physicians and laboratory professionals in the fields of reproductive medicine, urology, male infertility, andrology, and sexual medicine and will focus on optimizing outcomes for patients with male infertility.
Concentration will be on best physician practice in several key areas in the treatment of patients with male infertility, including pharmacologic management of erectile and ejaculatory dysfunction, investigation of erectile dysfunction as an indicator of metabolic syndrome, treatment of infertility in men with spinal cord injury, and the application of the newest laboratory findings to the treatment of male infertility.
LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:
1. Explain the basis for current recommendations regarding the pharmacologic management of erectile dysfunction and
ejaculatory dysfunction.
2. Describe the physiologic basis for erectile dysfunction as an indicator of metabolic syndrome.
3. Implement current recommendations for the treatment of infertility in men with spinal cord injury based on current
recommendations.
4. Summarize the recent revisions of the World Health Organization Semen Manual.
5. Apply the newest findings in epigenetics and advanced technologies to the treatment of male infertility.
To purchase a downloadable PDF of the PG course syllabus or syllabi, click here.
This session is a part of: